Sammelbandbeitrag

Dehydrogenases and enzyms of the mitochondrial electron transport chain as antiapicomplexan drug targets


AutorenlisteZocher, K; Rahlfs, S; Becker, K

Erschienen inApicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

HerausgeberlisteBecker, K

Jahr der Veröffentlichung2011

Seiten307-318

ISBN978-3-527-63388-3

DOI Linkhttps://doi.org/10.1002/9783527633883.ch16

SerientitelDrug discovery in infectious diseases

Serienzählung2


Abstract

Dehydrogenases and mitochondrial redox-associated processes are essentially involved in central energy metabolism of the apicomplexan parasites, including Plasmodium, Toxoplasma, Babesia, Eimeria, Cryptosporidium, Haemoproteus, and Neospora species. Despite the great potential of these enzymes and pathways to serve as target sites for novel antiparasitic control strategies, only a few of them have yet been characterized in detail. In this chapter, a review is provided of the current knowledge of mitochondrial enzymes of the electron transport chain and some dehydrogenases of the tricarboxylic acid (TCA) cycle of apicomplexan parasites, with respect to their function, structure, localization, and potential as drug targets.




Autoren/Herausgeber




Zitierstile

Harvard-ZitierstilZocher, K., Rahlfs, S. and Becker, K. (2011) Dehydrogenases and enzyms of the mitochondrial electron transport chain as antiapicomplexan drug targets, in Becker, K. (ed.) Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development. Weinheim: John Wiley & Sons, Ltd, pp. 307-318. https://doi.org/10.1002/9783527633883.ch16

APA-ZitierstilZocher, K., Rahlfs, S., & Becker, K. (2011). Dehydrogenases and enzyms of the mitochondrial electron transport chain as antiapicomplexan drug targets. In Becker, K. (Ed.), Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development (pp. 307-318). John Wiley & Sons, Ltd. https://doi.org/10.1002/9783527633883.ch16


Zuletzt aktualisiert 2025-21-05 um 15:09